Can Psychedelics Revolutionize Mental Healthcare? | Cybin Inc
Cybin Inc (OTCMKTS:CLXPF) is taking classical psychedelic molecules like MDMA, psilocybin, and DMT and turning them into useful therapeutics for mental health disorders like depression and addiction. Psychedelic medicines are gaining traction as more people and investors believe the drugs could revolutionize mental healthcare.
The pandemic has significantly increased the number of cases of depression, addiction and substance abuse. Unfortunately, long-term studies of traditional treatments of moderate depression, such as SSRIs, have shown effects no better than placebo.
To tackle these known issues, Cybin has had the support of many blue-chip biotech investors having raised $90 million to date. The backing is available as it is clear traditional therapies are not working for lots of mental conditions. Whereas, Studies from John Hopkins show a 71% response rate for patients using psilocybin to treat major depression. That is four times the effect compared with current treatments today. Not only is the response rate higher, but many patients using the magic mushroom also reported being free of depression for over five months.
Cybin has 50 molecules in their library – all under pharmaceutical regulation. Using those molecules, the company have several programs underway:
- a phase 2 clinical study for major depression
- a late preclinical program for alcohol use disorder using novel Deuterated Tryptamines.
- more programs coming online end of this year and the beginning of next.
Not only is Cybin working in drug development, but it is also focused on the associated psychotherapy to work alongside the drug. Another study concluded that when using MDMA to treat PTSD, the positive effects doubled. It is clear a combination of molecules and the therapy has positive synergistic effects.
As Cybin is still in the drug development stage of its business, the company expects to see its first treatment hit markets around 2024-2025. This is a longer-term play, but since Cybin is using well-known molecules with studied safety and efficacy, the road to market these drugs is much shorter than a normal biotech company starting drug development from scratch.
“The goal isn’t to spend investors money on brick-and-mortar and real estate, but to partner with chains of clinics that already exist to deliver psychotherapy services around Cybin’s molecules” – Cybin CEO Doug Drysdale
Watch the full interview to learn about Cybin’s patent filings, their drug library, clinic partnerships, and how they are looking to revolutionize the mental healthcare space.
Original article: Can Psychedelics Revolutionize Mental Healthcare? | Cybin Inc
©2021 Midas Letter. All Rights Reserved.
Source: https://midasletter.com/2021/05/can-psychedelics-revolutionize-mental-healthcare-cybin-inc/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).